The global health landscape is evolving with Brazil battling bird flu-related trade restrictions, Nestle USA eliminating ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...

MannKind Corporation (NASDAQ:MNKD) aims to release the topline results from the full pediatric study with safety extension in ...

J.J. Spaun is the U.S. Open champion with a strong connection to the Travelers Championship. It was five years ago when he ...

Background: Clinical studies suggest that inhaled corticosteroids reduce exacerbations and improve health status in chronic obstructive pulmonary disease (COPD). However, their effect on mortality is ...

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic ...

Patient Reported Outcomes with Use of Inhaled Technosphere Insulin (T1) (Board 827) Saturday, June 21, 2025 – 12:30 to 1:30 p.m. (Central) Presenter: Dr. Peter Calhoun ...

MannKind Corporation will present its inhaled insulin product, Afrezza, at the American Diabetes Association's 85th Scientific Sessions in Chicago from June 20-23, 2025. Dr. Michael J. Haller will ...